07
Oct
Oct
XPOVIO, from Karyopharm Therapeutics, is the first and only prescription medicine approved in the U.S. for the treatment of multiple myeloma
Always Be a Step Ahead
Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.
Subscribe to AMI's Insights Newsletter Today.